Indications of radiation therapy in non metastatic breast cancer;Indications de la radiothérapie dans le cancer du sein non métastatique

Revue Medicale Suisse

Volumn 3, Issue 130, 2007, Pages 2398-2404

  Sozzi, Wendy Jeannerez ^a   Mirimanoff, René Olivier ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST SURGERY; CANCER CONTROL; CANCER RADIOTHERAPY; CARCINOMA IN SITU; HUMAN; INVASIVE CARCINOMA; POSTOPERATIVE CARE; REVIEW; TREATMENT INDICATION;

BREAST NEOPLASMS; FEMALE; HUMANS; RADIOTHERAPY, ADJUVANT;

EID: 36148931803     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Bulliard JL, De Landtsheer JP, Levi F. Results from the Swiss mammography screening program. Eur J Cancer 2003;39:1761-9.
2. ** Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
3. ** Fisher B,Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
4. Blichert-Toft M, Rose C,Anderson JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy : Six years of life-table analysis. Danish breast cancer cooperative group. J Natl Cancer Inst Monogr 1992;11:19-25.
5. van Dongen JA,Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast conserving therapy with mastectomy : European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst 2000:92:1143-50.
6. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995;332:907-11.
7. Arriagada R, Le MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer : Patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy breast cancer group. J Clin Oncol 1996;14:1558-64.
8. * Liljegren G, Holmberg L, Bergh J, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer : A randomized trial. J Clin Oncol 1999;17:2326-33.
9. * Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma : Long-term results of a randomized trial. Ann Oncol 2001;12:997-1003.
10. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer : An update. J Natl Cancer Inst 1996;88:1659-64.
11. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer : 6-year analysis of the Scottish trial. Lancet 1996;348:708-13.
12. Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features : Results of a randomized study. Br J Cancer 2001;84:164-9.
13. ** Early breast cancer trialists' collaborative group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival : An overview of the randomised trials. Lancet 2005;366:2087-106.
14. Fisher B, Dignam J, Mamounas EP, et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors : Eight-year results from National surgical adjuvant breast and bowel project (NSABP) B-13 and first report of finding from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 1996;14:1982-92.
15. Fisher B, Bryant J, Digman JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002;20:4141-9.
16. Hughes K, Stewart H, Everington D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-7.
17. * Fyles A, McCready D, Manchul L, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351:963-70.
18. ** Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378-87.
19. * Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer : Results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997;15:963-8.
20. Teissier E, Hery M, Ramaioli A, et al. Boost in conservative treatment : 6 years results of randomized trial. Breast Cancer Res Treat 1998;50:287.
21. Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC «boost versus no boost» trial. Radiother Oncol 2000;55:219-32.
22. Newman LA, Kuerer HM. Advanced in breast conservation therapy. J Clin Oncol 2005;23:1685-97.
23. Jones HA, Antonini N, Hart G, et al. Significance of margins of excision on breast cancer recurrence. Eur J Cancer 2004;147: abstract 316.
24. * Antonini N, Jones H, Horiot JC, et al. Effect of age and radiation dose on local control after breast conserving treatment : EORTC 22881-10882. Radiother Oncol 2007;82:265-71.
25. * Vrieling C, Collette L, Fourquet A, et al. Can patient- treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 2003;39:932-44.
26. van der Leest M, Evers L, van der Sangen MJC, et al. The safety of breast-conserving therapy in breast cancer patients of 40 years and younger. Cancer 2007;109:1957-64.
27. ** Overgaard M, Hansen P, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
28. * Overgaard M, Jensen M, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen : Danish breast cancer cooperative DBCG 82c randomized trial. Lancet 1999;353:1641-8.
29. Tennvall-Nittby L, Tenegrup I, Landberg T, et al. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II: The South Sweden Breast Cancer Trial. Act Oncol 1993;32:641-6.
30. ** Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node- positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
31. Olson JE, Neuberg D, Pandya KJ, et al. The role of radiotherapy in the management of operable locally advanced breast cancer results of a randomized trial by the Eastern cooperative oncology group. Cancer 1997;79:1138-49.
32. Ernster VL, Barclay J, Kerlilowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-8.
33. ** Bijker N, Meijnen P, Peterse JL, et al. Breast conserving treatment with or without radiotherapy in ductal carcinoma-in-situ : Ten-year results of European organisation for research and treatment of cancer randomized phase III trial 10853 - a study by EORTC Breast cancer cooperative group and EORTC Radiotherapy group. J Clin Oncol 2006;24:3381-7.
34. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National surgical adjuvant breast project (NSABP) eight-year update of Protocol B-17 : Intraductal carcinoma. Cancer 1999;86:429-38.
35. * Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ : An update of the National surgical adjuvant breast and bowel project experience. Semin Oncol 2001;28:400-18.
36. Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia and New Zealand : Randomized controlled trial. Lancet 2003;362:95-102.
37. Omlin A, Amichetti M, Azria D, et al. Boost radiotherapy in young women with ductal carcinoma in situ : A multicentre, retrospective study of the Rare cancer network. Lancet Oncol 2006;7:652-7.
38. Early breast cancer trialists' collaborative group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival : An overview of the randomized trials. Lancet 2005;365:1687-717.
39. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10-years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation : Experience of the Eastern cooperative oncology group. J Clin Oncol 1999;17:1689-700.
40. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and chemotherapy with or without tamoxifen and without radiotherapy : Results from five national surgical adjuvant breast and bowel project randomized trials. J Clin Oncol 2004;22:4247-54.
41. * Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003;21:555-63.
42. Mikeljevic JS, Haward R, Johnston C, et al. Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery. Br J Cancer 2004;90:1343-8.
43. Recht A. Integration of systemic therapy and radiation therapy for patients with early-stage breast cancer treated with conservative surgery. Comprehensive review. Clin Breast Cancer 2003;4:104-13.
44. Colleoni M, Bonetti M, Coate AS, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. J Clin Oncol 2000;18:584-90.
45. Bellon JR, Come SE, Gelman RS, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer : Update results of a prospective randomized trial. J Clin Oncol 2005;23:1934-40.
46. Fiets We, Helvoirt van RP, Nortier JWR, et al. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF versus AC) in breast cancer : A prospective comparative study. Eur J Cancer 2003;39:1081-8.
47. Shapiro CL, Harrigan-Hardenberg P, Gelman R, et al. Cardiac effects of adjuvant doxorubicin and radiav tion therapy in node positive breast cancer patients. J Clin Oncol 1998;16:3493-501.
48. Azria D, Gourgou S, Sozzi WJ, et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 2004;91:1251-60.
49. Bentzen S, Skoczylas K, Overgaard M, et al. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996;88:918-22.